Stocks and Investing Stocks and Investing
Tue, June 23, 2020
Mon, June 22, 2020

Andrew Fein Initiated (APRE) at Hold and Held Target at $600 on, Jun 22nd, 2020


Published on 2024-10-27 08:26:30 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "Aprea Therapeutics, Inc." (APRE) at Hold and Held Target at $600 on, Jun 22nd, 2020.

Andrew has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $780 on, Wednesday, April 15th, 2020


This is the rating of the analyst that currently disagrees with Andrew


  • Madhu Kumar of "Baird" Initiated at Buy and Held Target at $900 on, Tuesday, April 21st, 2020
Contributing Sources